Hypertension in pregnancy has been associated with decreased future risk of breast cancer in many but not all studies. In the Marin Women’s Study, pregnancy-induced hypertension was shown to interact with the T allele of a functional IGF1R gene variant, rs2016347, to result in lower breast density, as well as decreased breast cancer risk. Our objective was to explore these findings in a larger sample of women from the California Teachers Study (CTS).
The CTS cohort consists of over 130,000 female educators. DNA was available from a nested case–control study, which included 2,030 non-Hispanic white women who developed breast cancer and 1,552 controls. The current study included all participants from the case–control group with a self-reported history of preeclampsia (80 cases/57 controls).
Comparing TT to GG genotypes revealed adjusted odds ratios of 0.38 (CI 0.13, 1.14) for all invasive breast cancers, 0.26 (CI 0.07, 0.89) for hormone receptor-positive (HR+) breast cancers, 0.15 (CI 0.04, 0.56) for those with age at first birth (AFB) < 30, and 0.10 (CI 0.02, 0.49) for those with AFB < 30 and HR+ breast cancers. Trend analysis yielded p values of 0.09, 0.03, 0.005, and 0.004 respectively, suggesting a biological effect for each T allele.
Study findings indicate that the T allele of IGF1R variant rs2016347 is associated with a significant reduction in breast cancer risk in women with a history of preeclampsia, most marked for HR+ breast cancer and in women with AFB < 30.
Peng HY, Xue M, Xia AB (2011) Study on changes of IGF-I and leptin levels in serum and placental tissue of preeclampsia patients and their associativity. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 27(2):192–194 PubMed
Robajac D, Masnikosa R, Miković Ž, Mandić V, Nedić O (2015) Oxidation of placental insulin and insulin-like growth factor receptors in mothers with diabetes mellitus or preeclampsia complicated with intrauterine growth restriction. Free Radic Res 49(8):984–989. doi: 10.3109/10715762.2015.1020798CrossRefPubMed
Key TJ, Appleby PN, Reeves GK, Roddam AW, Endogenous Hormones and Breast Cancer Collaborative Group (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11(6):530–542. doi: 10.1016/S1470-2045(10)70095-4CrossRefPubMed
Prebil LA, Ereman RR, Powell MJ, Jamshidian F, Kerlikowske K, Shepherd JA et al (2014) First pregnancy events and future breast density: modification by age at first pregnancy and specific VEGF and IGF1R gene variants. Cancer Causes Control 25(7):859–868. doi: 10.1007/s10552-014-0386-2CrossRefPubMedPubMedCentral
Powell M, Prebil LA, Rose S, Jamshidian F, Benz C, Ereman R. Insulin-like growth factor-1 receptor variant associated with decreased breast cancer risk in women with pregnancy-induced hypertension. San Antonio Breast Cancer Symposium [abstract P3-07-03] 2013
Ma H, Henderson KD, Sullivan-Halley J, Duan L, Marshall SF, Ursin G et al (2010) Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort. Breast Cancer Res 12(3):R35. doi: 10.1186/bcr2589CrossRefPubMedPubMedCentral
National Human Genome Research Institute, Genotype-Tissue Expression Project. GTEx Portal Version V6p, Accessed 10 January 2017
Blakely CM, Stoddard AJ, Belka GK, Dugan KD, Notarfrancesco KL, Moody SE et al (2006) Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy. Cancer Res 66(12):6421–6431. doi: 10.1158/0008-5472CrossRefPubMed
Barton M, Santucci-Pereira J, Russo J (2014) Molecular pathways involved in pregnancy-induced prevention against breast cancer. Front Endocrinol (Lausanne). doi: 10.3389/fendo.2014.00213
Katz TA, Liao SG, Palmieri VJ, Dearth RK, Pathiraja TN, Huo Z et al (2015) Targeted DNA Methylation Screen in the Mouse Mammary Genome Reveals a Parity-Induced Hypermethylation of IGF1R That Persists Long after Parturition. Cancer Prev Res (Phila) 8(10):1000–1009. doi: 10.1158/1940-6207.CAPR-15-0178CrossRefPubMedCentral
Thordarson G, Slusher N, Leong H, Ochoa D, Rajkumar L, Guzman R et al (2004) Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-alpha activation via the mitogen-activated protein kinase pathway. Breast Cancer Res 4:R423–R436 CrossRef
- Functional IGF1R variant predicts breast cancer risk in women with preeclampsia in California Teachers Study
Mark J. Powell
Julie Von Behren
Christopher C. Benz
- Springer International Publishing
Neu im Fachgebiet Onkologie
e.Med Kampagnen-Visual, Mail Icon II